Atrial fibrillation as prognostic factor of myocardial
infarction and/or acute heart failure

J 2011

Atrial fibrillation as prognostic factor of myocardial infarction and/or acute heart failure

ŠPINAR, Jindřich; Ondřej LUDKA; Milan SEPŠI; Olatunde Adetola AJIBONA; Jiří PAŘENICA et al.

Základní údaje

Originální název

Atrial fibrillation as prognostic factor of myocardial infarction and/or acute heart failure

Autoři

ŠPINAR, Jindřich; Ondřej LUDKA; Milan SEPŠI; Olatunde Adetola AJIBONA; Jiří PAŘENICA a Jiří JARKOVSKÝ

Vydání

Interventional Medicine & Applied Science, 2011, 2061-1617

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Maďarsko

Utajení

není předmětem státního či obchodního tajemství

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/11:00053766

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

atrial fibrillation; myocardial infarction; acute heart failure

Změněno: 2. 11. 2011 13:04, Mgr. Michal Petr

Anotace

V originále

Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation with consequence deterioration of atrial mechanical function. It has an incidence of approximately 6 million people in European Union as a result of the aging population and affects about 1 percent of patients younger than 60 years and about 8 percent of patients older than 80 years [2, 10]. AF is also the most common supraventricular arrhythmia in patients with acute myocardial infarction (MI) and/or acute heart failure (AHF), complicating its course with an incidence between 6–21% in hospitalized patients with MI although recent advances in pharmacological treatment of myocardial infarction has probably changed the impact of this arrhythmia and vice versa. These two diseases (AF + MI) are a growing health concern all over the world and when one considers the occurrence of these two diseases simultaneously, the relevance of AF in the course of MI and vice versa cannot be overemphasized in cardiovascular health care and more importantly its treatment and prevention. This article therefore aims to correlate data from controlled studies to summarize the incidence of AF in MI and vice versa and the impact of pharmacotherapy. Data from our registry Brno (3502 patients with MI and/or AHF) show that AF is not a predictor of short-term mortality in patients with myocardial infarction and/or heart failure, but is a strong predictor of long-term mortality.

Návaznosti

MSM0021622402, záměr

Název: Časná diagnostika a léčba kardiovaskulárních chorob

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Časná diagnostika a léčba kardiovaskulárních chorob

Citovat

ŠPINAR, Jindřich; Ondřej LUDKA; Milan SEPŠI; Olatunde Adetola AJIBONA; Jiří PAŘENICA a Jiří JARKOVSKÝ. Atrial fibrillation as prognostic factor of myocardial infarction and/or acute heart failure. Interventional Medicine & Applied Science. 2011, roč. 3, č. 3, s. 104–107. ISSN 2061-1617.

@article{956068,
   author = {Špinar, Jindřich and Ludka, Ondřej and Sepši, Milan and Ajibona, Olatunde Adetola and Pařenica, Jiří and Jarkovský, Jiří},
   article_number = {3},
   keywords = {atrial fibrillation; myocardial infarction; acute heart failure},
   language = {eng},
   issn = {2061-1617},
   journal = {Interventional Medicine & Applied Science},
   title = {Atrial fibrillation as prognostic factor of myocardial infarction and/or acute heart failure},
   volume = {3},
   year = {2011}
}

TY  - JOUR
ID  - 956068
AU  - Špinar, Jindřich - Ludka, Ondřej - Sepši, Milan - Ajibona, Olatunde Adetola - Pařenica, Jiří - Jarkovský, Jiří
PY  - 2011
TI  - Atrial fibrillation as prognostic factor of myocardial infarction and/or acute heart failure
JF  - Interventional Medicine & Applied Science
VL  - 3
IS  - 3
SP  - 104–107
EP  - 104–107
SN  - 20611617
KW  - atrial fibrillation
KW  - myocardial infarction
KW  - acute heart failure
N2  - Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterized by uncoordinated atrial activation with consequence deterioration of atrial mechanical function. It has an incidence of approximately 6 million people in European Union as a result of the aging population and affects about 1 percent of patients younger than 60 years and about 8 percent of patients older than 80 years [2, 10]. AF is also the most common supraventricular arrhythmia in patients with acute myocardial infarction (MI) and/or acute heart failure (AHF), complicating its course with an incidence between 6–21% in hospitalized patients with MI although recent advances in pharmacological treatment of myocardial infarction has probably changed the impact of this arrhythmia and vice versa. These two diseases (AF + MI) are a growing health concern all over the world and when one considers the occurrence of these two diseases simultaneously, the relevance of AF in the course of MI and vice versa cannot be overemphasized in cardiovascular health care and more importantly its treatment and prevention. This article therefore aims to correlate data from controlled studies to summarize the incidence of AF in MI and vice versa and the impact of pharmacotherapy. Data from our registry Brno (3502 patients with MI and/or AHF) show that AF is not a predictor of short-term mortality in patients with myocardial infarction and/or heart failure, but is a strong predictor of long-term mortality.
ER  -

ŠPINAR, Jindřich; Ondřej LUDKA; Milan SEPŠI; Olatunde Adetola AJIBONA; Jiří PAŘENICA a Jiří JARKOVSKÝ. Atrial fibrillation as prognostic factor of myocardial infarction and/or acute heart failure. \textit{Interventional Medicine \&{} Applied Science}. 2011, roč.~3, č.~3, s.~104–107. ISSN~2061-1617.

Přehled o publikaci